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Abstract 
[word count: 150] 
 
Background: Long term conditions (LTC) often coexist with depression and 
anxiety.  
Aims: To assess the effectiveness of stepped care psychological therapies for 
patients with LTC. 
Method: Data from 28498 patients were analysed using regression to model 
depression (PHQ-9) and anxiety (GAD-7) outcomes. Post-treatment 
symptoms and effect sizes (d) were estimated for cases with and without 
LTC, controlling for covariates. The likelihood of access and response to 
intensive psychological interventions was also examined. 
Results: Higher post-treatment symptoms were predicted for patients with 
musculoskeletal problems (d = .22 to .27), COPD (d = .26 to .33), diabetes (d 
= .05 to .13) and psychotic disorders (d = .50 to .58). Most LTC were 
associated with greater odds of accessing high intensity therapies (HIT), yet 
HIT cases continued to have higher average post-treatment symptoms.  
Conclusions: Some LTC are associated with greater intensity of care and 
poorer outcomes after therapy. 
Declaration of Interest: None. 
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Long term conditions (LTC) are highly prevalent in the general population 
affecting approximately 20% of people1 above the age of 16 and 58% of 
people over the age of 60.2 Among the more prevalent LTC in the general 
population are hypertension, chronic pain, gastrointestinal disorders, 
asthma, arthritis, diabetes, heart disease and chronic obstructive pulmonary 
disease.1,3 Multi-morbidity is common3 and these LTC carry a huge financial 
cost to health services, accounting for approximately 70% of total health and 
social care expenditure in public healthcare systems like the UK National 
Health Service.2 This highlights the need to treat both LTC and mental 
health problems concurrently. Although access to psychological care has 
been recommended as part of integrated care for LTC sufferers,4 it is possible 
that the effect of psychological interventions for mental health problems may 
be attenuated by LTC. For example, Dickens and collaborators5 reviewed the 
efficacy of psychological interventions for depression in patients with 
coronary heart disease and concluded that clinical trials show mixed 
evidence with small effect sizes favouring Cognitive Behavioural Therapy 
(CBT) as the treatment of choice for this population. Similar conclusions 
were reached in a systematic review of psychological interventions for 
persistent pain, which indicates modest effects for CBT in depression and 
anxiety symptom reductions.6 Clinical trials reviewed in these meta-analyses 
often include participants with highly disabling LTC treated in specialist 
services or hospital settings, and therefore it is unclear if these findings are 
reflective of outcomes from routinely delivered therapy in primary care 
settings, where the majority of LTC patients are treated. The objective of this 
study was to investigate the clinical effectiveness of primary care 
psychological interventions for depression and anxiety in a large naturalistic 
sample, comparing outcomes between patients with and without LTC. 
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Method 
 
Setting and interventions 
Retrospective clinical case records for a cohort of psychological therapy 
patients were analysed. The data was gathered as part of routine clinical 
care across a psychological therapy service in the north of England which 
was linked to the national Improving Access to Psychological Therapies (IAPT) 
programme.7 The study was conducted as a service evaluation using fully 
de-identified data, and therefore did not require ethical approval. Patients 
provided informed consent for their anonymous data to be used for audit, 
evaluation and research purposes. Patients accessing the service presented 
with depression and anxiety related problems and received evidence-based 
interventions organised in a stepped care model.8 The majority accessed 
brief (<8 sessions) low intensity guided self-help (GSH) interventions based 
on principles of cognitive behavioural therapy (CBT). Those with enduring 
symptoms after GSH and those with more severe conditions had access to 
high intensity (up to 20 sessions) therapies including CBT, interpersonal 
psychotherapy, counselling for depression and EMDR for post-traumatic 
stress. 
 
Measures and data sources 
Consistent with the national IAPT programme, patients in the sample were 
asked to self-complete three standard outcome measures to monitor 
progress on a weekly basis. The PHQ-9 is a nine-item measure of major 
depression symptoms.9 Each item is rated on 4 ordinal response options 
(0="Not at all"; 3="Nearly every day"), resulting in a depression severity score 
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between 0-27. A cut-off ≥ 10 is used to detect clinically significant 
depression symptoms. The GAD-7 is a seven-item measure of anxiety 
symptoms; it is also rated using 4 ordinal response options (0="Not at all"; 
3="Nearly every day"), resulting in an anxiety severity score between 0-21.10 
A cut-off score ≥8 is recommended to identify the likely presence of a 
diagnosable anxiety disorder. The Work and Social Adjustment Scale (WSAS) 
is a measure of functioning across five domains: work, home management, 
social leisure activities, private leisure activities, and family and 
relationships.11 Each item is rated between 0 (no impairment) and 8 (very 
severe impairment), with a total severity score between 0 – 40. 
 
De-identified clinical assessment records were also collected for participants, 
including demographic (age, gender, ethnicity, employment, socioeconomic 
deprivation) and clinical information (primary diagnosis, baseline severity, 
use of psychotropic medication; number of treatment contacts; number of 
referrals into the service for each patient over a 5 year period, pre- and post-
treatment outcome measures described above). Self-reported LTC were 
gathered using a standardised checklist of chronic illnesses at the time of 
initial assessment.12 This checklist prompts clinicians to gather information 
about 15 specific conditions (see Table 2) including severe (psychotic) mental 
health problems and an option to note “other” unspecified conditions. 
Socioeconomic deprivation was assessed by matching participants’ home 
postcodes to the English Index of Multiple Deprivation13 and categorising 
cases into quintile levels of deprivation (categorical variable named IMD). 
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Sample characteristics 
A total of 32734 case records for gathered for patients who accessed 
psychological treatment (at least one session) over a period of 5 years 
between 2010 and 2015. Of these, 2676 (8.2%) were excluded because they 
had no recorded information about LTC, and a further 1560 (4.8%) were 
excluded because no baseline and end scores were available for at least one 
of the outcome measures (PHQ-9 or GAD-7). This resulted in a sample of 
28498 case records that were available for analysis.  
 
The mean age in the sample was 38.27 (SD = 13.94; range = 16 to 92); 
64.6% were females; 85.5% were of a White British background; and 36.6% 
were unemployed. Primary presenting problems recorded in clinical 
assessments are presented in Table 1; the most common were recurrent 
depression (38.5%), mixed anxiety & depression (26.0%) and generalised 
anxiety disorder (12.1%). Self-reported LTC are listed in order of prevalence 
in Table 2. Overall, 23.2% of patients reported having at least 1 LTC; the 
most common were asthma (6.8%), musculoskeletal problems (chronic pain; 
1.8%) and hypertension (1.7%). Approximately 68.0% of patients in this 
sample only received low intensity guided self-help interventions, and 32.0% 
accessed high intensity therapies. 
 
 
[Tables 1 and 2] 
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Statistical analysis 
The goals of the analysis were to predict depression (PHQ-9) and anxiety 
(GAD-7) symptom severity at the end of treatment, controlling for 
demographic and clinical characteristics described above, and to compare 
these outcomes between cases with and without LTC. Given the typically 
high correlations between the PHQ-9 and GAD-7 scales,14 we applied a 
seemingly unrelated regression (SUR) model.15 SUR models estimate several 
equations simultaneously when the error terms of these equations are 
potentially correlated, which is a likely scenario for the prediction equations 
from PHQ-9 and GAD-7 scores. These models have been applied previously 
to model correlated dimensions of patient reported outcomes and have been 
shown to increase the efficiency of estimates in such situations.16 As a 
sensitivity analysis, we repeated the SUR analysis using a dichotomous 
variable denoting the presence or absence of a LTC, instead of entering 
dummy variables for the different LTC categories. 
 
In order to compare outcomes between patients with and without LTC, we 
estimated effect sizes (Cohen’s d) based on comparing post-treatment 
outcomes between specific LTC groups versus the ‘No LTC’ category and the 
Root Mean Square Error of the respective part (e.g. PHQ-9 or GAD-7) of the 
SUR model. 
 
As a sensitivity analysis, we assessed differential item functioning (DIF) to 
verify if responses to the PHQ-9 and GAD-7 measures are comparable across 
LTC groups, or if differences in outcome scores could be biased in favour or 
against certain LTCs. Specifically, we aimed to assess if responses to 
individual PHQ-9 or GAD-7 items corresponded to the same 
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psychopathology severity levels across LTC groups. To achieve this, we 
applied logistic ordinal regressions standardising on latent variable 
estimates of depression and anxiety using a Generalised Partial Credit Model 
(uniform and non-uniform DIF), as described by Crane et al.17 We evaluated 
differences in Pseudo-R² values between regression models to assess 
whether the LTC categories explained a relevant amount of variance in final 
PHQ-9 and GAD-7 scores. 
 
Considering the stepped care context in which psychological interventions 
were provided to this sample, we carried out secondary analyses to 
investigate if LTC patients may differ in their probability to receive and 
respond to high intensity therapy, which would be plausible given their 
general higher level of distress and functional impairment. To test this 
hypothesis, we used the same predictors described above (in the SUR model) 
in a logistic regression model aiming to predict the likelihood of concluding a 
treatment episode at the higher step of care (high intensity therapy versus 
low intensity care as a reference category). In this analysis n = 29 (0.1% of 
total) case records were excluded because of inputting errors in the clinical 
database, which did not enable us to identify the assignment of cases to low 
or high intensity steps of care. Furthermore, we repeated the SUR analysis 
separately analysing cases that finished their treatment episode after 
accessing low (n = 18902) or high (n = 8884) intensity interventions. 
 
Since the amount of missing data was only minimal (nmiss = 683, 2.4% of 
available cases), no additional imputation analyses were undertaken. As 
expected, most missing data points were for the outcome measures (PHQ-9 
and GAD-7) and 390 cases did not have valid postcodes documented in 
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clinical records, so IMD could not be derived. Furthermore, IMD data could 
not be imputed, since it is a geographical rather than an individual 
characteristic. 
 
Results 
 
Seemingly unrelated regression equations (SUR) modelling 
As expected, the equations for PHQ-9 and GAD-7 outcomes were highly 
correlated. The correlation between the error terms of the two equations was 
large (r = .82) and statistically significant (Breusch-Pagan test; 
χ² = 18704.17, p < .001). The SUR model explained a moderate amount of 
variance in post-treatment outcomes (PHQ-9 = 34%; GAD-7 = 29%). Table 3 
presents the SUR model results in the full sample, which are interpreted 
below. In what follows, we refer to combined depression (PHQ-9) and anxiety 
(GAD-7) symptoms at the time of the last attended treatment session as 
‘post-treatment distress levels’. 
 
 
[Table 3] 
  
 
Analysis of demographic variables 
Age was significantly correlated with both outcomes, though the association 
was weak, equivalent to a reduction of 0.01 score points per year increase. 
Gender did not correlate with either measure. In contrast, unemployment 
was associated with higher average post-treatment distress; with an increase 
of +0.68 points for PHQ-9 and +0.54 points for GAD-7. Patients from South 
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Asian backgrounds, dual heritage and other ethnicities also had higher 
average post-treatment distress by comparison to patients from white British 
backgrounds. The IMD quintiles also show significant associations in the 
expected direction: Patients living in more socioeconomically deprived areas 
(as defined by their home postcode) tended to have greater symptom severity 
at the end of treatment, and there was an increasing trend in mean post-
treatment scores for each quintile of deprivation. 
 
Analysis of treatment-related variables 
Differences attributable to taking medication were small and not statistically 
significant. The number of referrals for psychological treatment (over the last 
5 years) was significantly associated with post-treatment outcomes. Each 
additional referral for care predicted an increase of +0.59 points for PHQ-9 
and +0.55 for GAD7. Since up to 11 referrals were observed in the dataset, 
this could account for substantially greater post-treatment symptom severity 
for patients with multiple treatment episodes. A greater number of treatment 
contacts (in the index treatment episode) was associated with lower average 
post-treatment distress; decreasing this by -0.25 PHQ-9 points per contact 
attended (-0.22 for GAD7). 
 
Some differences between diagnostic categories were observed. A patient 
with a diagnosis of depression (the reference category) will finish therapy 
with a predicted PHQ-9 score of 9.69 (SE = .08; marginal mean) and GAD-7 
= 8.45 (SE = .07). Some diagnoses were associated with higher post-
treatment distress by comparison to the above reference scores; these were 
obsessive compulsive disorder (GAD-7), post-traumatic stress disorder (PHQ-
9 and GAD-7), and eating disorders (PHQ-9). Diagnoses associated with 
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lower predicted distress levels compared to depression were generalised 
anxiety disorder (PHQ-9), panic disorder (PHQ-9) and somatoform disorders 
(PHQ-9). 
 
As expected, baseline severity (PHQ-9, GAD-7) and functional impairment 
(WSAS) measures were significantly correlated with post-treatment 
outcomes, such that more severely impaired cases were expected to have 
higher post-treatment distress severity. 
 
Analysis of LTC data 
After controlling for all of the above demographic and clinically relevant 
variables, five LTC categories were associated with higher post-treatment 
distress levels: chronic musculoskeletal problems, chronic obstructive 
pulmonary disease, severe mental health problems, diabetes, and "other" 
non-specified conditions. Figure 1 presents predicted marginal post-
treatment outcome scores and Sidak-adjusted 95% confidence intervals; this 
shows that estimated post-treatment means differed substantially across the 
categories of LTC. The figure also presents the estimated treatment effect 
sizes corresponding to each LTC category, by comparison to the reference 
group of cases without any self-reported LTC (and in relation to non-
explained variance in the regression model; RMSEPHQ-9 = 5.82; RMSEGAD-
7 = 5.14). The effect sizes for those 5 LTC categories associated with poorer 
outcomes range from small (around d = .20) to medium (around 0.50; 
according to Cohen18). 
 
[Figure 1] 
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Sensitivity and secondary analyses 
Our sensitivity analyses found no evidence of differential item functioning 
(DIF) on PHQ-9 or GAD-7 across LTC groups. The maximal difference in 
Pseudo-R² values across regression models was 0.001, which is far smaller 
than the recommended cut-off of .035,17 indicating that only very small 
amounts of variance in item responses were related to specific LTCs (details 
available in data supplement, tables DS1-DS8). 
 
The SUR model including a dichotomous variable (LTC vs. no LTC) resulted 
in an adjusted mean difference of +0.57 (SE = .09, p < .001) for the PHQ-9 
and +0.42 for GAD-7 (SE = .08, p < .001), which speaks for a general 
disadvantage of this LTC population after controlling for potentially 
confounding variables. However, this effect is rather small (ESPHQ = .10 and 
ESGAD = .08; coefficients standardised on regression root-mean-square error) 
and therefore modelling post-treatment outcomes for each specific LTC is 
more informative. When we repeated the SUR analysis in the separate 
samples of cases that finished treatment after low or high intensity 
interventions, the results (details available in data supplement, table DS9) 
were largely consistent with the main SUR model shown in Table 3. The only 
differences were found for COPD and diabetes cases. COPD continued to be 
associated with higher post-treatment PHQ-9 (B = 3.81, p < .001) and GAD-7 
(B = 2.34, p < .01) scores after high intensity interventions, but not after low 
intensity interventions (PHQ-9: B = 0.90, p > .05;  GAD-7: B = 0.75, p > .05). 
Diabetes continued to be associated with higher post-treatment PHQ-9 (B = 
1.30, p < .01) but not with GAD-7 (B = 0.50, p > .05) scores after high 
intensity interventions; no such associations were found for cases that only 
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accessed low intensity interventions (PHQ-9: B = 0.43, p > .05;  GAD-7: B = 
0.00, p > .05). 
 
Table 4 shows the results of the logistic regression model predicting the 
likelihood of receiving high intensity therapy. As expected, patients with 
most LTC had a significantly higher probability of receiving high intensity 
interventions (odds ratios = 1.23 to 1.66; all p < .05). The only exceptions to 
this were found for patients with cardiovascular conditions, epilepsy and 
severe (psychotic) mental disorders, who were no more likely to receive high 
intensity therapy by comparison to those without any self-reported LTC. 
 
 
[Table 4] 
 
 
Discussion 
 
The overall goal of this study was to compare the effects of routinely 
delivered psychological care for patients with and without self-reported LTC. 
We found that patients with certain LTC tend to finish psychological 
treatment with greater depression and anxiety severity. By comparison to 
patients without LTC, this trend was statistically significant for 
musculoskeletal problems (effect sizes d = .22 to .27), chronic obstructive 
pulmonary disease (d = .26 to .33), diabetes (d = .05 to .13), severe mental 
health problems (d = .50 to .58) and "other" non-specified conditions (d = .10 
to .11). These findings converge with some observations of small to moderate 
effect sizes reported by meta-analyses of psychological interventions.6,19-21 
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Furthermore, patients with most types of self-reported LTC (except 
cardiovascular conditions, epilepsy and severe mental disorders) were 
significantly more likely to receive more intensive and costly psychological 
interventions, consistent with their higher level of impairment and symptom 
severity. Accessing high intensity therapy continued to be associated with 
higher average post-treatment distress in secondary analyses, indicating 
that LTC patients are not necessarily better off after high intensity (versus 
low intensity) care in this primary care setting. We noted that, in particular, 
severe mental health problems (such as psychotic disorders) tended to be 
strongly associated with poorer outcomes, though the prevalence of such 
conditions was very small (0.5%) given the service’s remit to offer treatment 
for common mental health problems. This evidence may indicate that the 
intensity and type of interventions offered in this primary care setting are 
clearly inadequate to improve psychological distress symptoms in cases with 
a history of severe and enduring (i.e., psychotic) mental disorders. It is also 
plausible that those with severe mental disorders were identified as such 
during the early phases of low intensity interventions and appropriately 
referred onwards to secondary care / psychiatric services; hence explaining 
why these cases were not more likely to access high intensity therapies in 
this primary care setting. 
 
A range of other demographic and clinical factors were also associated with 
post-treatment outcomes. Baseline severity and impairment measures, 
employment status, socioeconomic deprivation and age have been shown to 
predict outcomes in comparable clinical samples and settings.22-24 In 
addition, the present results also indicate that patients from certain ethnic 
backgrounds (South Asian, dual heritage) and diagnostic groups (obsessive 
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compulsive disorder, post-traumatic stress disorder and eating disorders) 
may be at increased risk of poor treatment outcomes. 
 
The overall prevalence of self-reported LTC in this cohort of psychological 
treatment patients (23.2%) was comparable to general adult population 
estimates (20%) from England.1 Asthma was the most prevalent (identifiable) 
LTC (around 6% of patients); which may reflect the common co-existence of 
this condition with anxiety related problems. However, a comparison of 
specific categories reveals a disproportionately small representation of 
certain conditions such as hypertension (1.7% in our sample vs. 14.3% in 
the general population), musculoskeletal problems (1.8% vs. 14.0%), 
diabetes (1.5% vs. 3.8%), heart failure (0.1% vs. 2.0%), and chronic 
obstructive pulmonary disease (0.5% vs. 1.8%). These discrepancies possibly 
indicate that patients with certain conditions are much less likely to access 
psychological care; for example the large discrepancy for hypertension 
indicates a ratio of 1:12. This discrepancy might in some cases be explained 
by the existence of specialist teams for LTC sufferers; for example the local 
area for this cohort of patients had 2 specialist musculoskeletal treatment 
services. However, it is possible that some patients with LTC commonly 
treated in primary care clinics may be inadequately screened or seldom 
referred for mental health treatment. Recent research indicates that this 
may be the case for some patients with coronary heart disease and 
diabetes.25 
 
Strengths and limitations 
This large (N = 28,498) naturalistic cohort was adequately powered to assess 
the predictive value of multiple demographic and clinical variables, which 
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was optimally modelled using joint-prediction of correlated outcomes (PHQ-
9, GAD-7). Our analyses additionally contained another layer of robustness 
tests. It is important to establish measurement invariance to have 
confidence that outcome questionnaires can be interpreted similarly across 
different patient groups.26,27 Our sensitivity analyses found no evidence of 
differential item functioning in PHQ-9 or GAD-7, which indicates that results 
of these outcome measures have the same meaning across LTC and non-LTC 
groups in this sample. This finding supports the notion that post-treatment 
outcome differences between LTC groups are likely to represent actual 
differences in psychological distress, rather than measurement error or 
confounding of LTC symptoms with mental health symptoms.  
 
Some limitations to note include the reliance on self-reported long term 
conditions, as is common in large cohort and epidemiological studies.1,28 In 
particular, we did not have more specific information about the types of LTC 
of patients who endorsed the ‘other’ category in assessment records. 
Presenting problem categories for mental health issues were also likely to be 
error prone, since these were ascertained using brief screening measures12 
rather than structured diagnostic interviews. Future studies that gather LTC 
diagnoses recorded in medical records and structured diagnostic interviews 
may render more precise outcome prediction estimates. A further caveat is 
that the data from this study, albeit large, came from a single site in the 
north of England. Future replication studies using data from similar stepped 
care services in other regions would enable us to assess the extent to which 
these findings are generalizable. 
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Implications for clinical practice 
The impact of and need for integrated mental health services has often been 
discussed from a medical perspective, i.e. how psychological professionals 
could be brought into medical contexts.29,30 Specialist medical knowledge 
about LTC is a key element of success and the integration of medical 
expertise within mental health services could also help to improve treatment 
outcomes in these settings.  
 
Our observations raise questions about the effectiveness of routinely 
delivered stepped care psychological treatments for people with comorbid 
diabetes, chronic obstructive pulmonary disease and chronic pain. These 
results also mirror findings from research into health-related quality of life 
(QOL), where it is also found that certain LTC (e.g. chronic pain) and 
especially having multiple LTC can considerably undermine QOL and 
exacerbate psychological distress.31 Such studies highlight the importance of 
multi-disciplinary care aiming to target multiple facets of wellbeing, 
adjustment and QOL. It may be particularly important to offer integrated 
multi-disciplinary care for people with specific conditions described above. 
For example, collaborative care interventions can enhance self-management 
of depression symptoms for patients with diabetes and coronary heart 
disease.29 Overall, we conclude that standard stepped-care interventions are 
insufficient to support patients with multi-morbidity, especially if delivered 
in isolation from other healthcare specialists. Our observations concur with 
recent calls for closer integration of physical and mental healthcare.32  
 
Healthcare economies and policy makers should systematically investigate 
the prevalence of LTC in mental health services. This information could be 
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crucial to design and deliver more integrated care for patients with LTC, but 
can also serve to understand how the demographic and clinical profile of 
local populations could have an impact on service outcomes. This aspect is 
still underexplored, especially when thinking about new benchmarking 
models and quality indicators within primary care psychological services.33 
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Table 1. Primary presenting problems recorded in clinical 
assessments 
 
 
Description N = 
28,498 
% 
Recurrent depression 8,698 38.5 
Mixed anxiety & depression 5,887 26.0 
Generalised anxiety disorder 2,725 12.1 
Depressive episode 1,160 5.1 
Panic disorder 970 4.3 
Social phobia 540 2.4 
Obsessive compulsive disorder 643 2.8 
Post-traumatic stress disorder 565 2.5 
Specific phobia 290 1.3 
Bereavement 201 0.9 
Eating disorder 177 0.8 
Agoraphobia 163 0.7 
Somatoform disorder 149 0.7 
Alcohol related mental or behavioural disorder 40 0.2 
Bipolar affective disorder 22 0.1 
Does not meet diagnostic criteria for a common 
mental disorder 
379 1.7 
Not specified in records 5,889 20.7 
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Table 2. Self-reported long term medical conditions (LTC) 
 
 
 
 
Description N = 
28,498 
% 
None 21882 76.8 
Other (unspecified) 2316 8.1 
Asthma 1935 6.8 
Chronic musculoskeletal 507 1.8 
Hypertension 490 1.7 
Non-insulin-dependent diabetes mellitus 327 1.1 
Epilepsy 188 0.7 
Chronic obstructive pulmonary disease 137 0.5 
Coronary heart disease 137 0.5 
Severe (psychotic) mental health problems 134 0.5 
Insulin-dependent diabetes mellitus 111 0.4 
Cancer 114 0.4 
Stroke and transient ischaemic attack 76 0.3 
Multiple sclerosis 49 0.2 
Chronic kidney disease 41 0.1 
Heart failure 38 0.1 
Parkinson`s disease 16 0.1 
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Table 3. Estimated coefficients for the SUR model jointly 
predicting post-treatment depression (PHQ-9) and anxiety (GAD-7) 
severity 
 
 PHQ-9  GAD-7 
Variable B SE  B SE 
PHQ-9 (baseline severity) 0.31*** 0.00 
 
  
GAD-7 (baseline severity)   
 
0.33*** 0.00 
WSAS (baseline severity) 0.17*** 0.00 
 
0.13*** 0.00 
Age (years) -0.01** 0.00 
 
-0.01*** 0.00 
Female -0.07 0.07 
 
0.02 0.07 
Unemployed 0.68*** 0.07 
 
0.54*** 0.07 
Ethnicity: Dual heritagea 0.49* 0.23 
 
0.56** 0.20 
Ethnicity: South Asiana 1.29*** 0.18 
 
1.13*** 0.16 
Ethnicity: Black British, African or 
Caribbeana 
-0.37 0.25 
 
-0.38 0.22 
Ethnicity: Othera 0.53*** 0.15 
 
0.45*** 0.13 
2nd IMD quintileb -0.77*** 0.11 
 
-0.63*** 0.10 
3rd IMD quintileb -1.11*** 0.11 
 
-0.85*** 0.09 
4th IMD quintileb -1.36*** 0.11 
 
-1.03*** 0.10 
5th IMD quintileb -1.75*** 0.12 
 
-1.33*** 0.10 
Medication -0.30 0.18 
 
-0.20 0.16 
Number of referrals into service 0.59*** 0.03 
 
0.55*** 0.03 
Treatment contacts attended -0.25*** 0.01 
 
-0.22*** 0.01 
Recurrent depressionc 0.36 0.19 
 
0.29 0.17 
Mixed anxiety & depressionc 0.16 0.10 
 
0.22* 0.09 
Generalised anxiety disorderc -0.56*** 0.14 
 
-0.14 0.12 
Social phobiac -0.30 0.27 
 
-0.24 0.24 
Panic disorderc -0.43* 0.20 
 
-0.12 0.18 
Agoraphobiac -0.09 0.46  0.15 0.41 
Specific phobiac -0.23 0.36 
 
0.10 0.31 
Obsessive-compulsive disorderc -0.25 0.25 
 
0.69** 0.22 
Post-traumatic stress disorderc 0.55* 0.26 
 
1.01*** 0.23 
Bereavementc 0.76 0.42  0.69 0.38 
Eating disorderc 1.64*** 0.45 
 
0.71 0.40 
Somatoform disorderc -1.18* 0.49 
 
-0.66 0.43 
Does not meet CMD criteriac 0.38 0.31 
 
0.18 0.27 
Other diagnosisc 0.06 0.11  0.16 0.10 
Asthmad 0.17 0.14 
 
0.21 0.12 
Cancerd 0.48 0.55 
 
0.03 0.48 
Chronic Musculokeletald 1.56*** 0.26 
 
1.15*** 0.23 
COPDd 1.92*** 0.51 
 
1.35** 0.45 
Cardiovasculard 0.10 0.22 
 
-0.05 0.20 
Diabetesd 0.77** 0.29 
 
0.24 0.25 
Epilepsyd -0.07 0.43 
 
0.04 0.38 
Severe Mental Health Problemsd 3.36*** 0.51 
 
2.58*** 0.45 
Other LTCd 0.67*** 0.13 
 
0.52*** 0.11 
Constant 3.74*** 0.27 
 
3.15*** 0.24 
Observations 27,815   27,815  
R-squared 0.34   0.29  
Notes: SUR = seemingly unrelated regression; B = regression coefficient; SE = standard error; PHQ-9 = 
depression measure; GAD-7 = anxiety measure; WSAS = work & social adjustment scale; IMD = index of 
multiple deprivation (quintile groups); CMD = common mental disorder; LTC = long term medical 
condition; COPD = chronic obstructive pulmonary disease; a reference category: White British; b reference 
category: first IMD quintile; c reference category: depressive episode; d reference category: no self-reported 
long term condition; * p <.05; ** p <.01; *** p <.001 
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Table 4. Probability of accessing high intensity therapy for 
patients with LTC 
 
 
 
 
  95% Confidence intervals 
Long term condition (LTC) Odds Ratio Lower bound Upper bound 
Asthma 
1.23** 1.09 1.39 
Cancer 1.66* 1.03 2.65 
Chronic Musculoskeletal 1.47** 1.17 1.84 
COPD 1.60* 1.04 2.47 
Cardiovascular 1.15 0.94 1.40 
Diabetes 1.39* 1.07 1.79 
Epilepsy 0.99 0.68 1.44 
Severe (psychotic) mental health problems 1.00 0.64 1.57 
Other non-specified LTC 1.30*** 1.17 1.46 
* p <.05; ** p <.01; *** p <.001; all coefficients controlled for demographic and  
treatment-related variables as for the main analysis (see table 3) 
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Figure 1. Predicted post-treatment anxiety (GAD-7) and 
depression (PHQ-9) scores across LTC groups 
 
 
[Figure attached separately] 
 
Notes: Marginal post-treatment scores derived from seemingly unrelated regression model (table 3) jointly 
predicting GAD-7 (panel A) and PHQ-9 (panel B) for a patient starting with mean Age (38.38), PHQ-9 (15.17), 
and GAD-7 (13.38) scores. The y-axes of both plots present the potential range in scores and the effect sizes 
(Cohen’s d) are based on comparisons with the "No LTC" category and the Root Mean Square Error of the 
respective part of the regression model. † Coefficient significant (see table 1). 0 = no LTC; 1 = Asthma; 2 = 
Cancer; 3 = Chronic Musculoskeletal; 4 = COPD; 5 = Cardiovascular; 6 = Diabetes; 7 = Epilepsy; 8 = Severe 
(psychotic) mental health problems; 9 = other non-specified LTC. 
 

